Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Molecular changes in the progression of Barrett s oesophagus Zagorowicz E; Jankowski JPostgrad Med J 2007[Aug]; 83 (982): 529-35Barrett's oesophagus is a frequent complication of gastro-oesophageal reflux disease predicting oesophageal adenocarcinoma. The majority of Barrett's patients will not develop cancer, so that specific methods of identification of those at risk are required. Recent molecular studies have identified a selection of candidate biomarkers that need validation in prospective studies. They reflect various changes in cell behaviour during neoplastic progression. The ASPECT trial in the UK aims to establish whether chemoprevention with aspirin and a proton pump inhibitor will reduce adenocarcinoma development and mortality in patients with Barrett's oesophagus. It will also validate biomarkers for progression and clinical response and further study disease pathogenesis.|Aneuploidy[MESH]|Apoptosis[MESH]|Barrett Esophagus/*etiology/metabolism[MESH]|Biomarkers, Tumor/metabolism[MESH]|Cadherins/metabolism[MESH]|Cell Cycle[MESH]|Cell Proliferation[MESH]|Cyclooxygenase 2/metabolism[MESH]|Diagnosis, Differential[MESH]|Esophageal Neoplasms/*etiology/metabolism/prevention & control[MESH]|Humans[MESH]|Telomerase[MESH]|Tumor Necrosis Factor-alpha/metabolism[MESH] |